Keyphrases
Acyclovir
100%
Cutaneous Dissemination
22%
Double-blind Trial
11%
Duration of Viral Shedding
11%
Early Treatment
11%
Immunocompromised children
11%
In Vitro Sensitivity
11%
Infections In Immunocompromised Hosts
100%
Nineteen
11%
No Significant Difference
11%
Placebo
11%
Placebo Groups
11%
Pulmonary Involvement
11%
Randomized Placebo-controlled Trial
11%
Second Episode
11%
Serious Complications
11%
Skin Healing
11%
Varicella
33%
Varicella Zoster Virus
22%
Varicella-zoster Virus Infection
100%
Vesicle Formation
11%
Vidarabine
33%
Virus Isolate
11%
Zoster
33%
Pharmacology, Toxicology and Pharmaceutical Science
Aciclovir
100%
Chickenpox
33%
Herpes Zoster
100%
Immunocompromised Patient
100%
Infection
11%
Placebo
33%
Varicella Zoster Virus
22%
Vidarabine
33%